Health In Tech (HIT) Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

GAAP Revenue: $8.1 million, down 13.5% from $9.3 million in Q2 2025.

Total Revenue for H1 2026: $16.8 million, slightly down from $17.3 million in H1 2025.

Contracted Revenue: $32.3 million for the first half of 2026, with $17.3 million recognized in H1 and $14 million expected in H2.

Pipeline Revenue: $66.3 million as of July 31, 2026, with a conversion rate expected between 15% to 40%.

Adjusted EBITDA: Negative $1.3 million for Q2 and negative $2.6 million for H1, compared to positive EBITDA of $1.6 million and $2.8 million in the prior year.

Net Loss: $2.5 million for Q2 or $0.04 per diluted share, compared to net income of $0.6 million or $0.01 per diluted share in Q2 2025.

Cash Position: $6.5 million in cash and cash equivalents, with total assets of $29.6 million.

2Strategic Updates and Business Highlights

Distribution Network Growth: Increased to 933 brokers, third-party administrators, and agencies, up nearly 20% year-over-year.

Platform Enhancements: Significant updates rolled out, including AI-driven risk insights and improved quoting functionalities.

New Product Launch: HitRix, a marketplace for large group self-funded stop-loss insurance, is expected to launch in the next few weeks.

3-Year Rate Stabilization Program: Successfully contracted the first employer group, with ongoing discussions with various governmental entities.

3Forward Guidance and Outlook

2026 Revenue Guidance: Reaffirmed guidance of $45 million to $50 million for the full year, supported by contracted revenue and pipeline metrics.

Sales Cycle: Anticipated to accelerate with the launch of HitRix and onboarding of an A-rated carrier, which is expected to enhance business opportunities significantly.

4Bad News, Challenges, or Points of Concern

Revenue Decline: The decrease in GAAP revenue was attributed to a timing issue related to the onboarding of a new carrier rather than a demand problem.

Increased Operating Expenses: Total operating expenses rose to $7.3 million from $5.6 million year-over-year, driven by higher sales and marketing costs.

Negative EBITDA: Continued investment in growth resulted in negative adjusted EBITDA, raising concerns about short-term profitability.

Accounts Receivable Days: Increased to 55 days in H1 2026 compared to 20 days in H1 2025, indicating potential cash flow management issues.

5Notable Q&A Insights

Carrier Ratings Impact: The transition to an A-rated carrier is expected to significantly enhance business opportunities, particularly with larger brokerage firms that require such ratings.

Sales Cycle Insights: Smaller groups can close deals in a day, while larger groups typically take about 90 days, impacting the timing of revenue recognition.

Feedback on New Products: Positive feedback from brokers on the upcoming HitRix platform suggests strong market interest and potential for increased pipeline revenue.

Pipeline Growth: The company anticipates a substantial increase in pipeline revenue as they continue to onboard new partners and expand their offerings. Overall, HIT is navigating a transitional phase with strategic investments and product launches aimed at long-term growth, despite facing short-term revenue challenges and increased operational costs.